Clinical Trial Update: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a Phase 1/2 clinical trial evaluating autologous adipose tissue–derived mesenchymal stem cells for knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED